Yield10 Financial Statements From 2010 to 2024

YTENDelisted Stock  USD 1.90  0.04  2.06%   
Yield10 Bioscience financial statements provide useful quarterly and yearly information to potential Yield10 Bioscience investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Yield10 Bioscience financial statements helps investors assess Yield10 Bioscience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Yield10 Bioscience's valuation are summarized below:
Yield10 Bioscience does not presently have any fundamental gauges for analysis.
Check Yield10 Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yield10 Bioscience's main balance sheet or income statement drivers, such as , as well as many indicators such as . Yield10 financial statements analysis is a perfect complement when working with Yield10 Bioscience Valuation or Volatility modules.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Yield10 Bioscience Company Shares Owned By Insiders Analysis

Yield10 Bioscience's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Yield10 Bioscience Shares Owned By Insiders

    
  12.59 %  
Most of Yield10 Bioscience's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yield10 Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 12.59% of Yield10 Bioscience are shares owned by insiders. This is 20.01% lower than that of the Biotechnology sector and 38.97% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 24.78% lower than that of the firm.

Yield10 Bioscience Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Yield10 Bioscience's current stock value. Our valuation model uses many indicators to compare Yield10 Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Yield10 Bioscience competition to find correlations between indicators driving Yield10 Bioscience's intrinsic value. More Info.
Yield10 Bioscience is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Yield10 Bioscience's earnings, one of the primary drivers of an investment's value.

About Yield10 Bioscience Financial Statements

Yield10 Bioscience investors utilize fundamental indicators, such as revenue or net income, to predict how Yield10 Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts. Yield10 Bioscience operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

Pair Trading with Yield10 Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Yield10 Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yield10 Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Yield10 Stock

  0.83IPI Intrepid PotashPairCorr
  0.79AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.78IE Ivanhoe ElectricPairCorr
  0.72MHGVY Mowi ASA ADRPairCorr
  0.66CTVA CortevaPairCorr
The ability to find closely correlated positions to Yield10 Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Yield10 Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Yield10 Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Yield10 Bioscience to buy it.
The correlation of Yield10 Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Yield10 Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Yield10 Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Yield10 Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Yield10 Stock

If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities